🇺🇸 FDA
Patent

US 10293056

Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases

granted A61KA61K48/00A61K48/0008

Quick answer

US patent 10293056 (Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases) held by The Board of Regents of the University of Texas System expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K48/00, A61K48/0008, A61K9/0019, A61K9/127